Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis-Reference-Cited by-同舟云学术

Differential usefulness of biomarkers thymus and activation-regulated chemokine and soluble CD30 during enteric coated mycophenolate sodium and cyclosporine therapy in atopic dermatitis

Published:2010-09 Issue:3 Volume:63 Page:e70-e72
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Kwakkel-van Erp Johanna M.,Haeck Inge M.,Paantjens Annelieke W.M.,van de Graaf Ed A.,van Ginkel Walter G.J.,Knol Mirjam J.,de Bruin-Weller Marjolein S.,Lammers Jan-Willem J.,Knol Edward F.,Bruijnzeel-Koomen Carla,Otten Henny G.

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. Clinical validation and guidelines for the SCORAD index: consensus report of the European task force on atopic dermatitis;Kunz;Dermatology,1997

2. Cyclosporine A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention;Bottari;Allergy,1999

3. Serum thymus and activation-regulated chemokine (TARC) and cutaneous T cell-attracting chemokine (CTACK) levels in allergic diseases: TARC and CTACK are disease-specific markers for atopic dermatitis;Hijnen;J Allergy Clin Immunol,2004

4. Serum thymus and activation regulated chemokine levels post-lung transplantation as a predictor for the bronchiolitis obliterans syndrome;Paantjens;Clin Exp Immunol,2008

5. Pre-transplant soluble CD30 is associated with bronchiolitis obliterans syndrome after lung transplantation;Bauwens;J Heart Lung Transplant,2006

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are blood cytokines reliable biomarkers of allergic disease diagnosis and treatment responses?;Journal of Allergy and Clinical Immunology;2022-08

2. Inclusion of Older Adults in Randomized Clinical Trials for Systemic Medications for Atopic Dermatitis;JAMA Dermatology;2020-11-01

3. Recent trends in disease severity and quality of life instruments for patients with atopic dermatitis: A systematic review;Journal of the American Academy of Dermatology;2016-11

4. Recent Advances in Pharmacotherapeutic Paradigm of Mild to Recalcitrant Atopic Dermatitis;Critical Reviews™ in Therapeutic Drug Carrier Systems;2016

5. Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis;Archives of Dermatological Research;2011-12-07